Real-world Experience of Rituximab in Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is a relapsing–remitting disease often requiring more than one line of therapy. Rituximab is a recommended second-line therapy, but the real-world data on its efficacy and safety from resource constraint settings is limited. We aimed to analyze the safety and efficacy o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Hematol Blood Transfus
Main Authors: Mishra, Kundan, Kumar, Suman, Jandial, Aditya, Sahu, Kamal Kant, Sandal, Rajeev, Ahuja, Ankur, Khera, Sanjeev, Uday, Yanamandra, Kumar, Rajiv, Kapoor, Rajan, Verma, Tarun, Sharma, Sanjeevan, Singh, Jasjit, Das, Satyaranjan, Chatterjee, Tathagat, Sharma, Ajay, Nair, Velu
Formato: Artigo
Idioma:Inglês
Publicado em: Springer India 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239077/
https://ncbi.nlm.nih.gov/pubmed/34267459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-020-01351-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados